Form D · Biotechnology

Ascent Industries Corp.

Vancouver, A1 · CIK 0001725861

Offering snapshot reported Oct 21, 2020 · SEC filing

Reported sold
$87.7K
Offering amount: $87.7K
Investors reported
5
Form D · investor count
Minimum accepted
$1.3K
Reported outside-investor minimum
First sale
Sep 14, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 21, 2020Initial$87,670No comparison5SEC filing
Mar 26, 2018Amendment$476,670$19,496vs Jan 3, 20189SEC filing
Jan 3, 2018Initial$457,174No comparison9SEC filing
Jan 3, 2018Amendment$457,174$0vs Jan 3, 20189SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$1.34K
Form D file number
021-378494
Total offering amount was CDN $500,000, of which CDN $117,477.52 (USD $87,669.79) was subscribed in the United States.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
James PoelzerNone

Source: Form D, filed Oct 21, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Philip Campbell Director, Executive
Elizabeth Coles Executive
Drew Malcolm Promoter
Drew Malcom Director
Mark Parr Promoter
Reid Parr Director, Executive, Promoter
James Poelzer Director, Executive
Andrew Robinson Director
Jeremy South Director
John Sweeney Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
800 543 Granville St
Vancouver, A1, V6C 1X8